Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Blood Research|April 28, 2022
Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CTKwai Han Yoo
International Journal of Hematology|January 23, 2018
Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trialKwai Han Yoo, Hyewon Lee, Cheolwon Suh, et al.
International Journal of Nanomedicine|September 20, 2019
Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regenerationSong Kwon, Kwai Han Yoo, Sun Jin Sym, et al.
Journal of Nanobiotechnology|January 12, 2023
Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugsJun-Young Park, Gyu-Ho Lee, Kwai Han Yoo, et al.
Blood Research|December 24, 2025
Awareness and real-world practices in chronic lymphocytic leukemia: insights from a nationwide survey of Korean hematologistsSeungah Cha, Seok Jin Kim, Kwai Han Yoo, et al.
Blood Advances|October 8, 2025
Predictive markers for the efficacy of CAR T-cell therapy: the interplay between CAR T-cell fitness and systemic immunityKwai Han Yoo, Szymon Szymura, Zhenyuan Dong, et al.
Blood Research|November 21, 2025
Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin's lymphomaJun Ho Yi, Young Hoon Park, Myung-Won Lee, et al.
Journal of Korean Medical Science|January 2, 2015
Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case reportHee Jin Kwon, Kwai Han Yoo, In Young Kim, et al.
BMC Molecular and Cell Biology|December 14, 2022
Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytesSoyoung Hwang, Se-Hee Kim, Kwai Han Yoo, et al.
Acta Haematologica|October 18, 2014
Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphomaKwai Han Yoo, Ji Yun Lee, Sung Hee Lim, et al.
Pageof 5